[go: up one dir, main page]

NO20063917L - Fremgangsmate for syntese av N-[3-(3-cyanopyrazol[1,5A]pyrimidin-7-yl)-fenyl]-N-etyl-acetamid - Google Patents

Fremgangsmate for syntese av N-[3-(3-cyanopyrazol[1,5A]pyrimidin-7-yl)-fenyl]-N-etyl-acetamid

Info

Publication number
NO20063917L
NO20063917L NO20063917A NO20063917A NO20063917L NO 20063917 L NO20063917 L NO 20063917L NO 20063917 A NO20063917 A NO 20063917A NO 20063917 A NO20063917 A NO 20063917A NO 20063917 L NO20063917 L NO 20063917L
Authority
NO
Norway
Prior art keywords
formula
phenyl
ethyl
acetamide
synthesis
Prior art date
Application number
NO20063917A
Other languages
English (en)
Norwegian (no)
Inventor
Katalin Szoke
Laszlo Czibula
Laszlo Dobay
Eva Werkne Papp
Judit Nagyne Bagdy
Gabor Tarkanyi
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO20063917L publication Critical patent/NO20063917L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20063917A 2004-02-02 2006-09-01 Fremgangsmate for syntese av N-[3-(3-cyanopyrazol[1,5A]pyrimidin-7-yl)-fenyl]-N-etyl-acetamid NO20063917L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0400325A HUP0400325A3 (en) 2004-02-02 2004-02-02 Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates
PCT/HU2005/000008 WO2005073235A2 (en) 2004-02-02 2005-01-31 Process for the synthesis of n- [3-(3-cyanopyrazolo [1,5a] pyrimidin-7-yl)-phenyl]-n-ethyl-acetamide

Publications (1)

Publication Number Publication Date
NO20063917L true NO20063917L (no) 2006-11-01

Family

ID=89981959

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063917A NO20063917L (no) 2004-02-02 2006-09-01 Fremgangsmate for syntese av N-[3-(3-cyanopyrazol[1,5A]pyrimidin-7-yl)-fenyl]-N-etyl-acetamid

Country Status (9)

Country Link
EP (2) EP1711501B1 (ru)
JP (1) JP2007519700A (ru)
AT (2) ATE438647T1 (ru)
DE (2) DE602005012365D1 (ru)
EA (1) EA010830B1 (ru)
HU (1) HUP0400325A3 (ru)
NO (1) NO20063917L (ru)
RS (1) RS20060427A (ru)
WO (1) WO2005073235A2 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005099712A2 (en) * 2004-04-19 2005-10-27 Sanmar Speciality Chemicals Limited Process for preparation of n-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide
WO2006070244A2 (en) * 2004-11-22 2006-07-06 Bakulesh Mafatlal Khamar A process for the preparation of zaleplon

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
US5714607A (en) * 1995-12-01 1998-02-03 American Cyanamid Company Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
ES2223311T1 (es) * 2001-06-12 2005-03-01 Biogal Gyogyszergyar Rt. Procedimiento para la preparacion de n-(3-(3-cianopirazol(1,5-a)pirimidin-7-il)fenil)-n-etilacetamida (zaleplon).
WO2003011228A2 (en) * 2001-08-01 2003-02-13 Biogal Gyogyszergyar Rt Purification and crystalline forms of zaleplon
PL207322B1 (pl) * 2002-05-14 2010-11-30 Adamed Społka Z Ograniczoną Odpowiedzialnością Sposób wytwarzania zaleplonu

Also Published As

Publication number Publication date
RS20060427A (en) 2008-08-07
ATE420882T1 (de) 2009-01-15
WO2005073235A2 (en) 2005-08-11
EP1711501B1 (en) 2009-01-14
EP1950213A3 (en) 2008-08-13
DE602005012365D1 (de) 2009-03-05
EA200601417A1 (ru) 2006-12-29
HU0400325D0 (en) 2004-04-28
EP1950213A2 (en) 2008-07-30
HUP0400325A2 (hu) 2005-09-28
DE602005015902D1 (de) 2009-09-17
JP2007519700A (ja) 2007-07-19
HUP0400325A3 (en) 2005-11-28
EP1711501A2 (en) 2006-10-18
EA010830B1 (ru) 2008-12-30
EP1950213B1 (en) 2009-08-05
WO2005073235A3 (en) 2005-10-06
ATE438647T1 (de) 2009-08-15

Similar Documents

Publication Publication Date Title
AU2009260044B2 (en) A process for the preparation of the apoptosis promoter ABT-263
US5756817A (en) O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same
JP4319245B2 (ja) ヒスタミン−3受容体拮抗薬
EP1527048B1 (fr) Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
US5106853A (en) Oxadiazole and its salts, their use in treating dementia
ES2199433T5 (es) 3,3-diarilpropilaminas, su uso y preparacion.
AU2004247487B2 (en) N-pyrrolidin-3-YL-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
US20130158265A1 (en) Sitagliptin, salts and polymorphs thereof
OA11572A (en) PyrroloÄ2,3-düpyrimidine compounds.
WO2018191815A1 (en) Processes for the preparation of acalabrutinib and intermediates thereof
EP0873308A1 (en) O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same
NO20063917L (no) Fremgangsmate for syntese av N-[3-(3-cyanopyrazol[1,5A]pyrimidin-7-yl)-fenyl]-N-etyl-acetamid
JPS58172379A (ja) 新規なキナゾリン誘導体
ES2259475T3 (es) Sintesis de compuestos utiles en la fabricacion de ketorolac.
KR102611847B1 (ko) 무스카린 수용체 길항 활성을 갖는 신규한 피롤리디늄 화합물 및 이의 용도
CN113121417A (zh) 一种新型哌啶衍生物及其药物用途
CA2189964A1 (en) Novel diaminomethylidene derivative
JPH1072426A (ja) 新規ムスカリン様レセプターアゴニスト
JP6368043B2 (ja) 三環式ラクタム化合物の製造法
WO2012022994A1 (en) Preparation process of vildagliptin
WO2009084031A2 (en) An improved process for preparation of (2e)-2-cyano-3-(3,4- dihydroxy-5-nitrophenyl)n,n-diethyl-2-propenamide polymorphic form a
EP1716129A1 (en) Piperazine derivatives which exhibit acivity as serotonin and noradrenaline re-upatke inhibitors
KR100998067B1 (ko) 비스(1-[(4-클로로페닐)페닐메틸]피페라진)-2,3-디벤조일 타르타르산 신규 중간체 염 및 이를 이용한 광학 활성적으로 순수한 1-[(4-클로로페닐)페닐메틸]피페라진을 분리하는 분리방법
CA3232921A1 (en) Oximes and their use in treatment of gba-related diseases
WO2010092286A1 (fr) Derives de n-[(2-aza-bicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application